155 related articles for article (PubMed ID: 16297347)
1. Preparation and development of equine hyperimmune globulin F(ab')2 against severe acute respiratory syndrome coronavirus.
Lu JH; Guo ZM; Han WY; Wang GL; Zhang DM; Wang YF; Sun SY; Yang QH; Zheng HY; Wong BL; Zhong NS
Acta Pharmacol Sin; 2005 Dec; 26(12):1479-84. PubMed ID: 16297347
[TBL] [Abstract][Full Text] [Related]
2. Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody.
Wang X; Ni B; Du X; Zhao G; Gao W; Shi X; Zhang S; Zhang L; Wang D; Luo D; Xing L; Jiang H; Li W; Jiang M; Mao L; He Y; Xiao Y; Wu Y
Antivir Ther; 2005; 10(5):681-90. PubMed ID: 16152762
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain.
Zhang CH; Guo ZM; Zheng HY; Lu JH; Wang YF; Yan XG; Zhao Y; DU XW; Zhang X; Fang L; Ling WH; Qi SY; Yu XB; Zhong NS
Chin Med J (Engl); 2004 Nov; 117(11):1625-9. PubMed ID: 15569476
[TBL] [Abstract][Full Text] [Related]
4. Development of a hyperimmune equine serum therapy for COVID-19 in Argentina.
Zylberman V; Sanguineti S; Pontoriero AV; Higa SV; Cerutti ML; Morrone Seijo SM; Pardo R; Muñoz L; Acuña Intrieri ME; Alzogaray VA; Avaro MM; Benedetti E; Berguer PM; Bocanera L; Bukata L; Bustelo MS; Campos AM; Colonna M; Correa E; Cragnaz L; Dattero ME; Dellafiore M; Foscaldi S; González JV; Guerra LL; Klinke S; Labanda MS; Lauché C; López JC; Martínez AM; Otero LH; Peyric EH; Ponziani PF; Ramondino R; Rinaldi J; Rodríguez S; Russo JE; Russo ML; Saavedra SL; Seigelchifer M; Sosa S; Vilariño C; López Biscayart P; Corley E; Spatz L; Baumeister EG; Goldbaum FA
Medicina (B Aires); 2020; 80 Suppl 3():1-6. PubMed ID: 32658841
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS-CoV F(ab')(2) in macaque.
Xu Y; Jia Z; Zhou L; Wang L; Li J; Liang Y; Zhao T; Ni B; Wu Y
Int Immunopharmacol; 2007 Dec; 7(13):1834-40. PubMed ID: 17996696
[TBL] [Abstract][Full Text] [Related]
6. Protection from infection with severe acute respiratory syndrome coronavirus in a Chinese hamster model by equine neutralizing F(ab')2.
Luo D; Ni B; Zhao G; Jia Z; Zhou L; Pacal M; Zhang L; Zhang S; Xing L; Lin Z; Wang L; Li J; Liang Y; Shi X; Zhao T; Zou L; Wu Y; Wang X
Viral Immunol; 2007 Sep; 20(3):495-502. PubMed ID: 17931120
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice.
Zhou L; Ni B; Luo D; Zhao G; Jia Z; Zhang L; Lin Z; Wang L; Zhang S; Xing L; Li J; Liang Y; Shi X; Zhao T; Zhou L; Wu Y; Wang X
Int Immunopharmacol; 2007 Mar; 7(3):392-400. PubMed ID: 17276898
[TBL] [Abstract][Full Text] [Related]
8. Equine immunoglobulin fragment F(ab')
Gupta D; Ahmed F; Tandel D; Parthasarathy H; Vedagiri D; Sah V; Krishna Mohan B; Khan RA; Kondiparthi C; Savari P; Jain S; Reddy S; Kumar JM; Khan N; Harshan KH
Clin Immunol; 2022 Apr; 237():108981. PubMed ID: 35306171
[TBL] [Abstract][Full Text] [Related]
9. PEGylation Prolongs the Half-Life of Equine Anti-SARS-CoV-2 Specific F(ab')
Xu M; Bi J; Liang B; Wang X; Mo R; Feng N; Yan F; Wang T; Yang S; Zhao Y; Xia X
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834803
[TBL] [Abstract][Full Text] [Related]
10. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
[TBL] [Abstract][Full Text] [Related]
11. Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain.
Zhang CH; Lu JH; Wang YF; Zheng HY; Xiong S; Zhang MY; Liu XJ; Li JX; Wan ZY; Yan XG; Qi SY; Cui Z; Zhang B
Vaccine; 2005 May; 23(24):3196-201. PubMed ID: 15837220
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.
Woo PC; Lau SK; Wong BH; Chan KH; Chu CM; Tsoi HW; Huang Y; Peiris JS; Yuen KY
Clin Diagn Lab Immunol; 2004 Jul; 11(4):665-8. PubMed ID: 15242938
[TBL] [Abstract][Full Text] [Related]
13. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862
[TBL] [Abstract][Full Text] [Related]
14. Purification of F(ab')2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield.
dos Santos MC; D'Império Lima MR; Furtado GC; Colletto GM; Kipnis TL; Dias da Silva W
Toxicon; 1989; 27(3):297-303. PubMed ID: 2728022
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection.
Nie Y; Wang G; Shi X; Zhang H; Qiu Y; He Z; Wang W; Lian G; Yin X; Du L; Ren L; Wang J; He X; Li T; Deng H; Ding M
J Infect Dis; 2004 Sep; 190(6):1119-26. PubMed ID: 15319862
[TBL] [Abstract][Full Text] [Related]
16. Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma.
Zhang Z; Xie YW; Hong J; Zhang X; Kwok SY; Huang X; Wong SW; Wong BL;
Transfusion; 2005 Jul; 45(7):1160-4. PubMed ID: 15987362
[TBL] [Abstract][Full Text] [Related]
17. [Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus].
Qiu LW; Tang HW; Wang YD; Liao JE; Hao W; Wen K; He XM; Che XY
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):277-81. PubMed ID: 15941537
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients.
Shi Y; Wan Z; Li L; Li P; Li C; Ma Q; Cao C
J Clin Virol; 2004 Sep; 31(1):66-8. PubMed ID: 15288616
[TBL] [Abstract][Full Text] [Related]
19. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection.
Li E; Han Q; Bi J; Wei S; Wang S; Zhang Y; Liu J; Feng N; Wang T; Wu J; Yang S; Zhao Y; Liu B; Yan F; Xia X
Front Immunol; 2023; 14():1066730. PubMed ID: 36875106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
